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http://dx.doi.org/10.1016/j.jds.2013.1Abstract Type-2 diabetes mellitus and periodontal disease are complex human diseases.
Pathogenesis of both ailments is multifactorial, involving chronic disease courses with varied
clinical presentations. It is well established in the scientific literature that both diseases are
interrelated; in particular, individuals suffering from diabetes are at a higher risk of developing
periodontitis. The present review analyzed, using a hypothetical model, the complex factors
that may influence the two diseases indirectly, including lifestyle, obesity, diabetes control,
oral health behavior, and serum inflammatory factors, and even quality of life. In this review,
special attention was given to exploring plausible theoretical or practical explanations of the
interrelations and the contemporary evidence base underpinning these. Since the impact of
individual general or oral health quality of life factors are substantial, it is very important
for health care professionals to appreciate the influence of these factors as controlling these
help assist in management of both type-2 diabetes and periodontal diseases thus reducing the
social burden of these two complex disease in various populations.
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2 L.R. Movva et alPeriodontitis and diabetes mellitus as complex
diseases
Periodontitis is a complex human disease, clinically expressed
as chronic inflammation at tooth-supporting structures
resulting from interactions between subgingival plaque bio-
films and the susceptible host defense system. Diabetes
mellitus (DM) is yet another human complex disease charac-
terized by metabolic disorders leading to various levels of
chronic hyperglycemia resulting from insufficient insulin
production or ineffective insulin action, or both. Even though
possible contributory interactions between diabetes and
periodontitis have been established and the support for a
bidirectional link appears to be rather clear, one needs to be
aware that available scientific evidence supports contro-
versies regarding the association between these two complex
diseases. Clinical evidence has been presented in the litera-
ture supportingdirect, indirect, or noassociationbetweenDM
and clinical periodontal status. The probable reason for these
different findings of associations could be due to the complex
and multifactorial nature of these two diseases, and hence
their diagnosis, classification and/or clinical trials such as
level of diabetic control,1 differences arising from different
periodontal disease data collection protocols,2 and differing
numbers of clinical patients used in the studies.3 Owing to the
complex nature of these two diseases other factors, apart
from the direct basic science mechanisms linking both dia-
betes and periodontitis, seem to be associated indirectly.
These other factors include general health behaviors, life-
style, and level of serum inflammatory mediators.4
The effect of periodontitis on general health and quality
of life remains ill defined, despite several studies. In a
study, type-2 DM patients, however, have been reported to
experience dry mouth and, in general, have inferior phys-
ical, role, and social functioning.5 The same study indicated
that, in addition to type-2 DM, dry mouth, dissatisfaction
with mouth or teeth, and poor financial status were
significantly associated with inferior general life quality
among the 204 Scandinavians surveyed.
The health-related behaviors and lifestyle factors that
play major roles in the development of both type-2 DM and
periodontal disease include general health behavior, diet
and obesity, oral health behavior, and psychological factors
and their associations with serum inflammatory factors such
as tumor necrosis factor alpha (TNF-a). The factors,
established, theoretical, or conceptual, that may
contribute to type-2 diabetes, and periodontitis and their
interactions and may potentially modify the corresponding
disease(s) outcomes are summarized in Fig. 1.
Taylor and coworkers6 recently provided a detailed re-
view on the relationship between glycemic control and
periodontal inflammation at molecular and cellular levels.
Their group demonstrated a considerable amount of infor-
mation on the direct impact of poor glycemic control on
microbial factors, cytokines, adipokines, immune cell
functions, cell stress, and advanced glycation end-products
and their receptor and alveolar bone homeostasis, as well as
some, but limited, information on the impact of microbial
and inflammatory factors of periodontal disease on diabetic
control. The aim of this present review is to summarize the
clinical evidence available for the associations between theabove mentioned health behaviors and lifestyle factors, and
both type-2 DM and poor periodontal health. In addition,
current evidence on the impact of periodontal disease on
diabetic mellitus and a model of such interaction will be
discussed. In particular, the study focuses on the in-
teractions between these two diseases and the aspects that
health care professionals should attempt to promote good
general and oral health for the affected people.
General health behaviors
The ideal general health behaviors include not smoking,
consuming fewer than 10 (if male) or five (if female) alco-
holic drinks per week, always wearing a seatbelt while in a
car whether as a driver or as a passenger, and participating
in an exercise activity such as brisk walking, aerobics,
sports, or heavy house-work at least three times a week.7
Good health behaviors measured in terms of smoking,
alcohol consumption, eating breakfast, hours of sleep,
hours of work, physical exercise, nutritional balance, and
mental stress are associated with higher natural killer cell
activity, which constitutes the first line of immunological
defense.8 In diabetic males, a healthy lifestyle and fewer
micro-vascular complications have been shown to be asso-
ciated with higher education.9 Among diabetic women,
however, the more educated perceived themselves as
healthier than those with less education, regardless of their
medical status.10 Diabetic patients with poor metabolic
control and a lower educational level report more compli-
cations, nervous problems, sick leave days, and disability
pensions and a lower level of physical activity than patients
with good or acceptable metabolic control.11 Diabetic fe-
males of a low social class face a higher risk of mortality
than both nondiabetic females and diabetic males of low
social classes.12
Poor general health behaviors, regardless of the DM
status, have been shown to be moderately associated with
poor periodontal conditions,13 whereas those who maintain
normal weight, engage in regular exercise, and have a high-
quality diet experience improved periodontal conditions.14
Diet and obesity
Obesity is defined as having excess body weight with an
abnormally high proportion of body fat. Body mass index
(BMI) is a simple measure of body fat based on body weight
and height and is used to identify overweight and obese
people. BMI is defined as weight in kilograms divided by
height in meters squared. The World Health Organization
(WHO) and the National Institute of Health defined over-
weight as a BMI of 25e29.9 kg/m2 and obesity as a BMI of
30 kg/m2 or higher. BMI cutoffs are based on data showing
that health risks increase with BMI> 25 kg/m2.15 The current
increase in the prevalence of obesity has been associated
with an increase in the prevalence of type-2 diabetes.16
Obesity is a known risk factor for type-2 diabetes, heart
disease, stroke, hypertension, osteoarthritis, sleep apnea,
and some forms of cancer.17 Overweight or obesity is the
single most important predictor of type-2 diabetes.18 The
risk of diabetes increases by approximately 9% with every
kilogram increase in the self-reported weight19 and by 4.5%
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Duration of obesity is also positively associated with the
development of type-2 diabetes.21 Obesity is associated
with increases in insulin resistance and glucose intolerance,
and exacerbates metabolic abnormalities related to type-2
diabetes, such as hyperinsulinemia, hyperglycemia, and
dyslipidemia. The expression of the proinflammatory cyto-
kine serum TNF-a in, and its secretion from, adipose tissue
are elevated in obesity, and this may have a role in the
insulin resistance of obesity and type-2 diabetes.22 Adipo-
nectin is another secretary product of adipose tissue that
may be involved in the development of type-2 diabetes in
susceptible obese individuals.23 Obesity thus complicates
the management of type-2 diabetes and makes it more
difficult to treat the disease pharmacologically. An addi-
tional complication is that several of the agents used to
treat type-2 diabetes, such as insulin, sulfonylureas, and
thiazolidinediones, promote weight gain.24 Obesity thus
increases morbidity and mortality from diabetes.
Patients with type-2 diabetes treated in behavioral
weight loss programs who reported the highest exercise
levels lost the maximum weight and had the largest re-
ductions in HbA1c, independent of weight loss at 1 year
from pretreatment.25 In persons with type-2 DM, exercise
improves cardiopulmonary fitness, reduces blood glucose
levels, improves insulin sensitivity, and reduces cardiovas-
cular risk by lowering blood pressure and improving dysli-
pidemia.26 Behavioral therapy programs generally result in
modest weight loss.25
Obesity is claimed to be significantly associated with
periodontal disease through the pathway of insulin resis-
tance.27 Serum TNF-a, a proinflammatory cytokine, pro-
duced from adipose tissue is known to play a predominant
role in inducing insulin resistance in obese patients.28
Conditions associated with obesity such as metabolic syn-
drome may exacerbate periodontitis.29 Obesity has a sig-
nificant association with periodontitis in terms of BMI, body
fat, and maximum oxygen consumption.30 However, the
association is limited to the younger obese population with
an increased prevalence of periodontal disease,31 and
periodontal disease is positively associated with total
cholesterol and low-density lipoprotein cholesterol.32 Long-
term observational studies also showed increased weight
and obesity to be associated positively with the progression
of periodontal disease33 and severity of probing pocket
depths.34 The progression of periodontal disease also seems
to be correlated with overweight and obesity diagnosed in a
Japanese cohort at least 5 years ago, indicating the dose-
dependent nature of their association.35Psychological factors
Depression and psychosocial factors are considered risk
factors for both type-2 DM36 and periodontal disease.37
Older women seem to suffer more from depression than
men.38 Although the highest rates of depression are found
among people under the age of 45 years, older adults are
more likely to be prescribed antidepressants.39 Prolonged
negative events may disturb the optimal functioning of host
defenses; consequently, individuals experiencing stress
may develop chronic diseases.40Stress and depressive symptoms have been shown to
influence the incidence of type-2 diabetes.37 The possible
mechanisms include influence of depressive symptoms on
behaviors such as physical activity and diet41 or on the
activity of hypothalamicepituitaryeadrenal axis and sym-
pathetic nervous systems.42 The odds of type-2 diabetes
have been reported to increase by about 13% with the
occurrence of each negative stressful life event.43 It has
also been reported that stressful life events related to
finance and work are indicators of poor metabolic health.44
An underlying biobehavioral mechanism of the impact of
stress on the progression of periodontal disease has been
suggested to act through two pathways. Stress may activate
several neuroendocrine systems including the hypothal-
amicepituitaryeadrenal axis and the sympathetic nervous
system, leading to a reduced potential of the host de-
fense,45 or may induce the development of the disease
through unhealthy lifestyle factors such as smoking.46
Increased work and psychological stress are associated
with poor oral health status.47 Psychosocial measures of
stress associated with financial strain and distress man-
ifested as depression are associated with severe peri-
odontal disease in the absence of adequate coping
behavior, suggesting that the effects of stress on peri-
odontal disease can be controlled by adequate coping be-
haviors.40 Dental anxiety is associated with periodontal
attachment loss48 and a higher number of teeth with
probing depths more than 6 mm, whereas satisfaction with
life is reported to be associated with flossing frequency.49
Chronic job-related and financial strains, depression, and
inadequate coping are all associated with risks of increased
clinical attachment loss.38 This association between stress
and depression is mediated largely through behavioral and
physiologic mechanisms.50 Psychological stress is also
associated with periodontal disease resistant to periodontal
treatment,51 whereas depression is associated with tooth
loss and chronic conditions associated with pain.52Diabetic control
With proper control of type-2 DM, therapists and patients
can minimize the health risks and burdens of affected in-
dividuals and society. It is recently advocated by the In-
ternational Diabetes Federation (IDF), based on the
available evidence, that an HbA1c level of <7.0% is
generally compatible with low diabetes-related micro- and
macrovascular complications.53 An IDF treatment algorithm
was proposed to the medical team in achieving the target
of <7.0% HbA1c, taking into consideration the local avail-
ability, access, and cost of therapeutic agents.54
Other than diabetologists or endocrinologists, general
medical practitioners, dietitians, exercise or fitness trainers,
podiatrists, ophthalmologists, dentists/hygienists, and
periodontists are key team members to promote and main-
tain the overall health of those affected by DM or even those
in a prediabetic state.55,56 Studies following up such collab-
orative comprehensive care have confirmed that favorable
DM management outcomes can be achieved.57 Obviously, to
control type-2 DM successfully, a comprehensive approach
appears essential because it remains arguable that oral
intervention alone can improve glycemic control.58
Figure 1 Simplified conceptual model demonstrating interactions between type-2 DM and periodontitis pathogenesis and
diseases outcomes. The upper left section (A) of the model indicates etiology of diabetes mellitus and the upper right section (B)
concerns etiology of periodontitis, and their related risk/modifying factors and corresponding interactions are highlighted
(Adapted from “The pathogenesis of human periodontitis: an introduction, Figure 1,” by R.C. Page, and K.S. Kornman, 1997,
Periodontol 2000, 19, p. 9e11. Copyright 1997, John Wiley & Sons Ltd. Adapted with permission.) In the middle section of the
model (C), interactions between diabetes mellitus and periodontitis at cell or tissue levels are summarized. The lower third
section (D) of the model indicates the symptoms of diabetes mellitus and gingivitis/periodontitis as well as their negative impact
on oral health-related quality of life and/or general quality of life. One- or two-way interactions or relationships (established:
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The ideal oral health behaviors comprise visiting a dentist
at least once a year in addition to visits for dental prob-
lems, at least daily toothbrushing, using an interdental
device such as flossing daily, using a wooden tooth pick
once or more per day, no snacking between meals, and
consuming no more than one cariogenic food a day.7 Phys-
ical activity is associated positively with the toothbrushing
behavior, whereas alcohol consumption and smoking are
correlated negatively with proper oral health behavior.59
The frequency of toothbrushing is correlated negatively
with sugar consumption among adolescents59 and is a pre-
dictive indicator of general health behavior.60 Poor oral
health behaviors affect the periodontal status through the
accumulation of plaque and calculus deposits.4
Good oral hygiene habits, by contrast, are associated
positively with healthy food consumption, use of vitamins,
and regular physical exercise among adolescents.61 It was
also reported that diabetic patients generally show poor oral
health behaviors; however, the absence of a control group
negated the test of association between poor oral health
behavior and type-2 DM.62 Nevertheless, systemically
healthy nondiabetic periodontitis patients were reported to
havea significantly highermean fasting blood glucose level.63
Serum inflammatory factors
A few inflammatory mediators or related serum molecules
such as interleukin-1 beta (IL-1b), IL-6, TNF-a, C-reactive
protein (CRP), intercellular adhesion molecule 1, and
vascular cell adhesion molecule 1 have been reported to be
associated with both type-2 DM and chronic periodontitis.
The proinflammatory cytokine TNF-a plays a role in the
development of obesity-linked insulin resistance22 through
inhibiting tyrosine kinase activity at insulin receptors. Phos-
phorylation of the insulin receptor by this tyrosine kinase is
known to be a cardinal step in the postreceptor events that
follow the binding of insulin to its receptor and interferes
with the insulin signaling cascade. The normal level of serum
TNF-a is 0.72  0.28 pg/mL. In DM, TNF-a production has
been found to be increased64 and TNF-a plasma levels seem
to be associated positively with metabolic control.12 High
levels of serum TNF-a in patients with insulin resistance may
be due to high levels of fasting insulin.65 The production and
activity of serum TNF-a are modulated by several oral anti-
diabetic agents.66 In addition, the relationships between
serum TNF-a, metabolic control, antidiabetic therapy, and
aging seem to be associated with an increase in serum TNF-a
plasma levels.67 This increase in serum TNF-a levels with
aging may be due to an age-associated increase in the per-
centage of body fat.68 The levels of serum TNF-a were
observed to reduce with weight loss.69
More recently, the cause and effect relation between
proinflammatory cytokines such as IL-1 and TNF-a, and
periodontal attachment loss has been established.70 Theunbroken line, speculative/unconfirmed: broken line) exist betwee
arrows, respectively. AGE Z advanced glycation end-product;
1Z intercellular adhesion molecule 1; ILZ interleukin; LPSZ lip
PMN Z polymorphonuclear neutrophil; TNF-a Z tumor necrosis facellular source of serum TNF-a in periodontal diseases
include monocytes, polymorphonuclear leukocytes, fibro-
blasts, epithelial cells, endothelial cells, and osteoblasts.
Once the critical levels of proinflammatory cytokine pro-
duction are reached, a local physiologic process becomes a
pathologic response.71 The increased serum TNF-a level, in
turn, may exacerbate pre-existing periodontal conditions
by stimulating fibroblasts to synthesize matrix degrading
enzymes72 or by stimulating osteoclasts to activate bone
resorption.73 Serum TNF-a can also induce the expression of
other mediators that amplify or sustain inflammatory re-
sponses, such as prostaglandins, and the production of lytic
enzymes, and enhance bacterial killing, phagocytic activ-
ity,74 and overproduction of serum TNF-a.71 Further syn-
ergistic action with IL-1 can enhance bone resorption.75
Successful periodontal management decreases circulating
serum TNF-a.76 Additionally, the reduction in circulating
serum TNF-a is correlated with an improvement in the
metabolic control of diabetes, possibly mediated through
an improvement in insulin resistance.77
Along with proinflammatory cytokines such as TNF-a,
other inflammatory mediators such as CRP and IL-6 also play
major roles in the development of impaired glucose intol-
erance prior to the diagnosis of type-2 diabetes.78 Probing
pocket depths and clinical attachment loss are also associ-
ated linearly with impaired fasting glucose levels prior to the
development of type-2 diabetes.79 It has also been reported
that increased inflammatory markers such as CRP, matrix
metalloproteinases-14, and tissue inhibitor of matrix
metalloproteinases-2 are involved in the progression of
periodontal inflammation associated with type-2 diabetes.80General- and oral-health-related quality of life
Obesity and diabetic complications have been reported to be
the main factors associated with an inferior health-related
quality of life,81 whereas dissatisfaction with mouth and
teeth and feeling of dry mouth have been reported to affect
the health-related quality of life of type-2 DM patients.5 So
far, reports regarding the oral health-related quality of life
(OH-QoL) for DM patients remain scarce. One recent report
indicated that dental caries and xerostomia confer negative
impacts on the OH-QoL of adolescents with type-1 DM.82 The
negative impact of advanced periodontal attachment loss in
poor OH-QoL, however, was established.83 Based upon the
fact that type-2 DM patients would experience more peri-
odontitis,84 it is fair to anticipate that type-2DMpatientsmay
have inferior OH-QoL because of dry mouth and poor peri-
odontal health. Further studies are needed to investigate
such relationships.Type-2 diabetes and periodontal diseases
Periodontal disease is considered the sixth complication of
diabetes85 and DM a risk factor for periodontal disease.86n various elements/factors, as indicated by single and double
CRP Z C-reactive protein; DM Z diabetes mellitus; ICAM-
opolysaccharide; OH-QoLZ oral health-related quality of life;
ctor alpha; VCAM-1 Z vascular cell adhesion molecule 1.
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disease is complex and to some extent controversial, as the
evidence has been advanced in support of both for and
against the association between diabetes and periodontal
disease. Emerging evidence portrays the association as bidi-
rectional87 as compared to the other opinions of unidirec-
tional association,88 in which severe periodontitis is
considered a risk factor of poor glycemic control.89 The as-
sociation between these two complex diseases can be
explained by two similar but distinct pathologic pathways: a
direct causal association in which the consequences of dia-
betes act as modifiers of periodontal disease expression90
and, alternatively, a common pathologic defect that results
in a host susceptible to either disease or both diseases.91
The prevalence of diabetes in patients with periodontitis
is double (12.5%) that seen in nonperiodontitis patient
(6.3%),92 even though no difference has been detected in the
number of etiologic factors or the degree of gingival changes
between the diabetic and control groups. However, patients
with poorly controlled diabetes suffer more from gingival
bleeding than those with good or moderate control.1 Calcu-
lus and poor metabolic control were thought to be the best
predictors for probing depth; patients with poor metabolic
control and calculus have a higher prevalence of the disease
and more extensive periodontal pockets than well or
moderately controlled diabetics.93 Metabolic control seems
to be less important in terms of the association with
attachment loss in the absence of calculus.
Age and number of standing teeth were reported to be
associated significantly with periodontal attachment loss.2
Good or moderate control of any complex human disease
is attributed to patient cooperation. Patients with well-
controlled diabetes might also be more cooperative
regarding their oral healthcare habits and dental care.14
Clinical attachment loss is more severe in diabetics than
in nondiabetics. Diabetics with poorly controlled diabetesFigure 2 Possible interrelationship between behavioral and basic
A modified version of the model developed by Kawamura et al hig
lationships (established: unbroken line, speculative/unconfirmed:
(single arrow) or two ways (double arrows). BMI Z body mass inde
metabolic control and periodontal status in type 2 diabetic patients
M. Kawamura, A. Tsurumoto, S. Fukuda, and H. Sasahara, 2001, J Pe
of Periodontology, Figure 1 modified with permission.experience greater attachment loss than those with well-
controlled diabetes.94 Diabetic men have a poorer peri-
odontal status than nondiabetic men.95 Similarly, diabetic
women also have a poorer periodontal status than nondia-
betic women.96 Further, diabetic patients aged 55e74 years
have more severe periodontal disease than patients aged
45e54 years and 75e90 years, and comparable age-
matched nondiabetics.3
A long duration of diabetes is also considered a risk factor
for periodontitis. An association between longer duration of
diabetes and severity of attachment loss has beenobserved.13
This correlation is similar to that of other complications of
diabetes, such as retinopathy and vascular disease.
Oral hygiene instructions were found to exert a positive
effect on fasting blood glucose levels, gingival crevicular
fluid volume, community periodontal index recordings, and
plaque index.97 Mechanical nonsurgical periodontal treat-
ment is able to assist in the reduction of the glycated he-
moglobin level in the blood, as reported by a recent meta-
analysis.98 Surgical periodontal treatment responses in di-
abetics were found to be similar to those in age- and sex-
matched nondiabetics.99 Meanwhile, glycemic control has
a positive influence on the gingival inflammation condition.
A reduction of inflammation along the gingival margin was
reported with the improvement of glycemic control, even
when no periodontal intervention was provided.100Interrelationship between type-2 DM and
periodontitisda simplified model
So far, researchers have been able to decipher only part of
the theoretical relationship between type-2 DM and peri-
odontitis. To a limited extent, certain relationships of
behavioral and basic science with these two complex
human diseases appear to be better appreciated (Fig. 2),3science, and type-2 diabetes mellitus and periodontal disease.
hlights the possible areas for intervention. Interactions or re-
broken line) between various elements/factors are one way
x. Note. Adapted from “Health behaviors and their relation to
: a model tested using a linear structural relations program,” by
riodontol, 72, p. 1246e53. Copyright 2001, American Academy
Type 2 DM and periodontitis 7and hopefully appropriate intervention aimed at changing
the key elements of the system may assist in the manage-
ment of both type-2 DM and periodontitis. However, there
remain substantial knowledge gaps, related in particular to
the common pathogenic mechanisms between diabetic
complications and periodontitis causation, as well as how
impaired general and oral health life quality can at the end
affect the behavior and hence the compliance of affected
individuals with diabetic control regimen and periodontal
health maintenance.
The scientific evidence presented demonstrates the as-
sociation between poor type-2 diabetic status and poor
periodontal health. This relationship seems to be influ-
enced by complex and multifactorial nature of both dia-
betes and periodontitis. Apart from the common
pathogenic pathways of periodontitis and diabetic compli-
cations such as impaired immune responses and poor wound
healing, other factors including lifestyle, obesity, and psy-
chological factors can negatively influence local as well as
systemic inflammatory mediators, which in turn may indi-
rectly lead to poor diabetic control and periodontal
destruction. It is therefore important to understand the
indirect associations between lifestyle, obesity, and psy-
chological factors for both type-2 diabetes and periodontal
disease, as modification of these factors may greatly
improve the management and prevention of both type-2
diabetes and periodontal disease in our communities.Conflicts of interest
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